Found: 3
Select item for more details and to access through your institution.
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 9, p. 8005, doi. 10.3390/ijms24098005
- By:
- Publication type:
- Article
Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 9, p. 986, doi. 10.1177/1060028015593369
- By:
- Publication type:
- Article
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00676-8
- By:
- Publication type:
- Article